Crewe Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,170
| Closed | -$169K | – | 741 |
|
|
2024
Q2 | $169K | Buy |
2,170
+213
| +11% | +$16.6K | 0.02% | 192 |
|
|
2024
Q1 | $133K | Buy |
+1,957
| New | +$133K | 0.02% | 231 |
|
|
2023
Q3 | – | Sell |
-1,920
| Closed | -$137K | – | 615 |
|
|
2023
Q2 | $137K | Sell |
1,920
-550
| -22% | -$39.4K | 0.02% | 175 |
|
|
2023
Q1 | $171K | Sell |
2,470
-129
| -5% | -$8.95K | 0.03% | 172 |
|
|
2022
Q4 | $176K | Hold |
2,599
| – | – | 0.03% | 166 |
|
|
2022
Q3 | $143K | Buy |
2,599
+175
| +7% | +$9.63K | 0.03% | 183 |
|
|
2022
Q2 | $160K | Buy |
2,424
+550
| +29% | +$36.3K | 0.04% | 158 |
|
|
2022
Q1 | $124K | Hold |
1,874
| – | – | 0.02% | 155 |
|
|
2021
Q4 | $109K | Hold |
1,874
| – | – | 0.02% | 130 |
|
|
2021
Q3 | $113K | Hold |
1,874
| – | – | 0.03% | 105 |
|
|
2021
Q2 | $112K | Sell |
1,874
-255
| -12% | -$15.2K | 0.03% | 108 |
|
|
2021
Q1 | $106K | Buy |
2,129
+5
| +0.2% | +$249 | 0.03% | 101 |
|
|
2020
Q4 | $106K | Buy |
2,124
+2,033
| +2,234% | +$101K | 0.04% | 96 |
|
|
2020
Q3 | $5K | Buy |
+91
| New | +$5K | ﹤0.01% | 348 |
|